Hepatocyte-derived exosome may be as a biomarker of liver regeneration and prognostic valuation in patients with acute-on-chronic liver failure

Jiao, Y; Lu, W; Xu, P; Shi, HL; Chen, DX; Chen, Y; Shi, HB; Ma, YM

Shi, HB; Ma, YM (corresponding author), Capital Med Univ, Beijing Youan Hosp, Beijing Inst Hepatol, Beijing 100069, Peoples R China.; Chen, Y (corresponding author), Capital Med Univ, Beijing Youan Hosp, Dept Liver Dis 4, Beijing Municipal Key Lab Liver Failure & Artific, Beijing 100069, Peoples R China.; Shi, HB; Ma, YM (corresponding author), Beijing Engn Res Ctr Precis Med & Transformat Hep, Beijing 100069, Peoples R China.

HEPATOLOGY INTERNATIONAL, 2021; 15 (4): 957

Abstract

Background The assessment of liver regeneration is particularly critical for patients with acute-on-chronic liver failure (ACLF). Exosome has both the......

Full Text Link